# Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers

> **NCT05864261** · PHASE4 · COMPLETED · sponsor: **Yi Fang** · enrollment: 74 (actual)

## Conditions studied

- Renal Anemia

## Interventions

- **DRUG:** JT1801 60ug
- **DRUG:** NESP 60ug

## Key facts

- **NCT ID:** NCT05864261
- **Lead sponsor:** Yi Fang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-15
- **Primary completion:** 2023-08-28
- **Final completion:** 2023-08-28
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05864261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05864261, "Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05864261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*